Literature DB >> 20441539

Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders.

Francisco A Villa1, Lena Gerwick.   

Abstract

Natural products, secondary metabolites, isolated from plants, animals and microbes are important sources for bioactive molecules that in many cases have been developed into treatments for diseases. This review will focus on describing the potential for finding new treatments from marine natural products for inflammation, cancer, infections, and neurological disorders. Historically terrestrial natural products have been studied to a greater extent and such classic drugs as aspirin, vincristine and many of the antibiotics are derived from terrestrial natural products. The need for new therapeutics in the four areas mentioned is dire. Within the last 30 years marine natural products, with their unique structures and high level of halogenation, have shown many promising activities against the inflammatory response, cancer, infections and neurological disorders. The review will outline examples of such compounds and activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441539     DOI: 10.3109/08923970903296136

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  41 in total

1.  Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor.

Authors:  Pradeep Cheruku; Alberto Plaza; Gianluigi Lauro; Jessica Keffer; John R Lloyd; Giuseppe Bifulco; Carole A Bewley
Journal:  J Med Chem       Date:  2012-01-05       Impact factor: 7.446

Review 2.  Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.

Authors:  William H Gerwick; Bradley S Moore
Journal:  Chem Biol       Date:  2012-01-27

Review 3.  Biologically active secondary metabolites from marine cyanobacteria.

Authors:  Joshawna K Nunnery; Emily Mevers; William H Gerwick
Journal:  Curr Opin Biotechnol       Date:  2010-10-26       Impact factor: 9.740

4.  Phylogenetic inferences reveal a large extent of novel biodiversity in chemically rich tropical marine cyanobacteria.

Authors:  Niclas Engene; Sarath P Gunasekera; William H Gerwick; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

5.  Light regulation on growth, development, and secondary metabolism of marine-derived filamentous fungi.

Authors:  Menghao Cai; Zhe Fang; Chuanpeng Niu; Xiangshan Zhou; Yuanxing Zhang
Journal:  Folia Microbiol (Praha)       Date:  2013-04-02       Impact factor: 2.099

6.  Identification of the First Marine-Derived Opioid Receptor "Balanced" Agonist with a Signaling Profile That Resembles the Endorphins.

Authors:  Tyler A Johnson; Laura Milan-Lobo; Tao Che; Madeline Ferwerda; Eptisam Lambu; Nicole L McIntosh; Fei Li; Li He; Nicholas Lorig-Roach; Phillip Crews; Jennifer L Whistler
Journal:  ACS Chem Neurosci       Date:  2016-11-22       Impact factor: 4.418

7.  Development of a Unified Enantioselective, Convergent Synthetic Approach Toward the Furanobutenolide-Derived Polycyclic Norcembranoid Diterpenes: Asymmetric Formation of the Polycyclic Norditerpenoid Carbocyclic Core by Tandem Annulation Cascade.

Authors:  Robert A Craig; Russell C Smith; Jennifer L Roizen; Amanda C Jones; Scott C Virgil; Brian M Stoltz
Journal:  J Org Chem       Date:  2018-03-19       Impact factor: 4.354

8.  Total Synthesis and Structural Reassignment of Lyngbyaloside C Highlighted by Intermolecular Ketene Esterification.

Authors:  Chia-Fu Chang; Eric Stefan; Richard E Taylor
Journal:  Chemistry       Date:  2015-06-23       Impact factor: 5.236

9.  Glycyrrhizic acid from licorice down-regulates inflammatory responses via blocking MAPK and PI3K/Akt-dependent NF-κB signalling pathways in TPA-induced skin inflammation.

Authors:  Wenfeng Liu; Shun Huang; Yonglian Li; Yanwen Li; Dongli Li; Panpan Wu; Quanshi Wang; Xi Zheng; Kun Zhang
Journal:  Medchemcomm       Date:  2018-07-19       Impact factor: 3.597

10.  The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.

Authors:  Bailey Miller; Aaron J Friedman; Hyukjae Choi; James Hogan; J Andrew McCammon; Vivian Hook; William H Gerwick
Journal:  J Nat Prod       Date:  2013-12-23       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.